Menora Mivtachim Holdings’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Menora Mivtachim Holdings’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-19,500	Closed	-$108K	–	88
2017 Q3	$108K	Sell	19,500 -9,840	-34%	-$50.8K	﹤0.01%	74
2017 Q2	$136K	Sell	29,340 -73,950	-72%	-$330K	0.01%	74
2017 Q1	$511K	Sell	103,290 -1,247,557	-92%	-$12M	0.03%	63
2016 Q4	$15M	Hold	1,350,847	–	–	0.77%	40
2016 Q3	$12.5M	Hold	1,350,847	–	–	0.69%	40
2016 Q2	$8.58M	Hold	1,350,847	–	–	0.48%	40
2016 Q1	$8.81M	Hold	1,350,847	–	–	0.53%	41
2015 Q4	$11M	Hold	1,350,847	–	–	0.7%	37
2015 Q3	$9.9M	Buy	1,350,847 +217,457	+19%	+$2.22M	0.74%	37
2015 Q2	$11.6M	Buy	1,133,390 +726,269	+178%	+$8.03M	0.88%	32
2015 Q1	$3.77M	Buy	+407,121	New	+$3.64M	0.3%	40

Other funds holding FOMX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Menora Mivtachim Holdings's FOMX Position: Q4 2017 in Review

Menora Mivtachim Holdings sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2017, closing a stake of 19,500 shares — an estimated $108K sold.

Menora Mivtachim Holdings first reported a position in FOMX in Q1 2015 and held it in 11 quarters. The position peaked at $15M in Q4 2016. 48 funds tracked by Wall St. Rank hold FOMX as of Q4 2017.

Menora Mivtachim Holdings reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
Menora Mivtachim Holdings sold 19,500 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2017, an estimated $108K.
Menora Mivtachim Holdings first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2015 and held it in 11 quarters.
Menora Mivtachim Holdings's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $15M in Q4 2016.
48 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2017.

Based on Menora Mivtachim Holdings's 13F filing for Q4 2017, filed 13 Feb 2018.